桑叶多糖SJB的结构分析和蛋白酪氨酸磷酸酯酶PTP1B抑制活性

通过DEAE-纤维素和凝胶过滤柱色谱对桑叶碱提粗多糖进行分级分离, 获得均一多糖SJB, 进行结构鉴定. 采用蛋白酪氨酸磷酸酯酶PTP1B体外模型对SJB进行降血糖活性测定. 结果表明: SJB的相对分子质量为5.4×104, 由鼠李糖、阿拉伯糖、葡萄糖、半乳糖、半乳糖醛酸组成的酸性杂多糖; 主链由1,2-、1,2,4-连接的鼠李糖和1,4-、1,3,4-连接的半乳糖醛酸组成; 侧链包括末端、1,5-、1,3,5-连接的阿拉伯糖; 末端、1,4-连接的葡萄糖以及末端、1,3-、1,4-、1,6-连接的半乳糖, 主要通过鼠李糖的O4位和半乳糖醛酸的O3位与主链相连. 该多糖为首次从桑叶中获得的酸性杂多糖. 20 μg/mL SJB对PTP1B的抑制率为31.7%.     

金钗石斛免疫活性多糖DNP-W1B的结构特征

从金钗石斛茎中获得了1个均一多糖组分DNP-W1B, 采用化学与光谱学结合的手段对其一级结构进行了解析. 结果表明, DNP-W1B分子量为7.7×10⁵, 比旋度²⁰_D=+81.3°(c0.3, H₂O), 由葡萄糖、 阿拉伯糖和半乳糖3种单糖组成, 摩尔比为6.2:3.1:0.9. DNP-W1B主链由1,4-和1,6-连接的葡萄糖残基组成, 在主链1,6-连接葡萄糖残基的4位形成分支, 支链由末端半乳糖残基和阿拉伯糖残基组成. 初步的免疫活性实验结果表明, DNP-W1B在体外能促进免疫细胞的增殖.     

野菊花中性多糖CIP-C的分离纯化及结构解析

以野菊花为原材料, 经热水提取、乙醇沉淀、DEAE-Sepharose Fast Flow和Sephacryl S-200 凝胶柱层析分离纯化, 得到1个水溶性的中性多糖CIP-C. 采用GC-MS、部分酸水解及甲基化分析等对该多糖的结构进行了解析. 结果表明, 该多糖主要由D-Man, D-Glc和D-Gal组成, 并含有少量的D-Fuc, L-Ara和D-Xyl, 其主链由β(或α)-D-1,4-Man, β-D-1,6-Glc和β-D-1,4-Gal组成, 而阿拉伯糖通过α-L-T-Araf和α-L-1,5-Araf连接形成阿拉伯聚糖支链或与β-D-1,4-Galp的O3位相连形成阿拉伯半乳聚糖支链.     

白术多糖的分离纯化与结构表征

采用UV, IR, NMR, GC-MS, 高碘酸氧化和Smith降解等物理化学方法对从白术根茎提取的白术多糖的纯度、理化性质和结构进行了表征. 以中药白术的根茎为原料, 通过热水(80 ℃)浸提和乙醇醇沉得到粗多糖, 再经DEAE-52阴离子交换柱层析分离和Sephadex G-200凝胶柱层析纯化, 得到一种水溶性的白术多糖(WAM). 经高效液相色谱(HPLC)分析, 多糖WAM是分子量约为3263的均一多糖. GC分析表明, WAM是由葡萄糖和半乳糖以摩尔比3.01:1构成的杂多糖. 甲基化分析、高碘酸氧化、Smith降解、部分酸水解、NMR和IR等分析结果表明, WAM具有多分支结构, 主链由β-D-1→3和β-D-1→3,6吡喃葡萄糖构成, 每个重复单元具有一个支链, 支链由β-D-半乳糖构成, 连接在主链葡萄糖的6位碳原子上.     

沙蒿籽水溶性胶多糖ASPI-A的结构与免疫活性的初步研究

从沙蒿籽中提取出水溶性胶多糖,经柱色谱分离纯化得到一种中性多糖组分ASPI-A.采用高效凝胶渗透色谱法(HPGPC)测定其为均一性多糖,平均分子量为5.42×104Da.经IR,GC部分酸水解、甲基化分析等方法对该多糖的化学结构进行了表征.结果表明,该多糖由阿拉伯糖、甘露糖、葡萄糖及半乳糖组成,其物质的量的比为1∶2.8∶4.9∶1.9.ASPI-A为多分支结构,以(1→4)-β-Glc构成主链,部分葡萄糖C6存在分支,由甘露糖以-4)Man(1-连接在葡萄糖C6位,Glc(1-和Gal(1-连接在甘露糖C4位构成.免疫活性实验结果表明,ASPI-A在10～50μg·mL-1浓度范围内对ConA诱导的小鼠T淋巴细胞增殖反应具有促进作用.     

白骨壤酸性果胶多糖HAM-3-Ⅱb-Ⅱ的结构分析

以分离纯化得到的白骨壤酸性多糖HAM-3-Ⅱb-Ⅱ为研究对象, 采用高碘酸氧化-Smith降解、部分酸水解以及甲基化分析等技术对该多糖的结构进行分析. 结果表明, HAM-3-Ⅱb-Ⅱ为典型的鼠李半乳糖醛酸聚糖I 型酸性果胶类多糖, 主链骨架包括: 1,4-连接的α-D-GalpA构成的无分支的半乳糖醛酸聚糖(光滑区)和通过α-D-GalpA的O4位与1,2-和1,2,4-L-Rhap的O2交替相连构成的含有较多分支的鼠李半乳糖醛酸聚糖(毛发区). 由T-、1,6-、1,3,6-、1,4-、1,4,6-D-Galp和T-、1,2-、1,3-、1,5-、1,2,5-、1,3,5-Aaraf聚合成的AGⅠ型阿拉伯半乳聚糖、AGⅡ型阿拉伯半乳聚糖、半乳聚糖以及阿拉伯聚糖, 构成了HAM-3-Ⅱb-Ⅱ的侧链部分, 通过Rha残基的O4位与主链相连.     

一种碱溶性灰树花菌丝体多糖GFM2A的制备和结构表征

以灰树花菌丝体为原料, 经过碱提取和柱色谱分离纯化, 得到一种碱溶性多糖(GFM2A). 经高碘酸氧化、Smith降解、乙酰解并采用GCMS, IR, 2D NMR等方法对该多糖的化学结构进行了表征. 结果表明, 该多糖由葡萄糖(Glc)、甘露糖(Man)和木糖(Xyl)组成, 其摩尔比为9∶2∶1, 其主链由6个α-1, 3-D-Glc和2个α-1,3-D-Man 构成, 且α-1,3-D-Glc残基O-4位有两个分支, 其中一个分支连接3个β-1,4-D-Glc, 另一个分支连接一个α-1,4-D-Xyl.     

桑白皮水提取多糖组分的分离纯化和结构特征

桑白皮为桑科植物桑Morus alba L的干燥根皮, 是临床上常用的中药. 采用沸水提取获得桑白皮中的多糖, 用乙醇沉淀、阴离子交换柱层析、凝胶过滤层析等方法进行分离和纯化, 从水提粗多糖中得到均一多糖CMA-a-1, CMA-a-5和CMA-b1-1. 应用糖组成分析、甲基化分析及IR, NMR等光谱学方法研究桑白皮多糖的结构及性质. 结果表明, CMA-a-1, CMA-a-5均为淀粉类多糖, 前者结构类似于支链淀粉, 但O-6位上取代的支链中含有1,6-连接葡萄糖, 平均链长为23; 而后者更接近于直链淀粉, 平均链长为30. CMA-b1-1为以1,2-连接的鼠李糖及1,4-连接的半乳糖醛酸为主链的RG-I型果胶类多糖, 具有多种形式的由阿拉伯糖、半乳糖、木糖等构成的支链. CMA-b1-1对SMMC7721肝癌细胞生长具有抑制作用, 对L02正常肝细胞生长则没有抑制作用. 本研究表明桑白皮水提多糖中主要是淀粉类和果胶类多糖.     

当归多糖ASP3及其水解产物的NMR光谱分析

对当归多糖ASP3的糖链结构进行分析. 分别采用0.2 mol/L三氟乙酸(Trifluoroacetic acid, TFA)和内切-α-(1→4)-聚半乳糖醛酸酶(EndoPG)对ASP3进行部分酸水解和酶水解, 并对水解前后多糖组分的1D和2D NMR光谱特征进行分析. 实验结果表明, ASP3是一种果胶多糖. GalpA和Rhap位于多糖分子的主链, 由1→4-D-GalpA相连形成的“光滑区”(半乳糖醛酸聚糖)是其主要组成部分; 由α-(1→4)-GalpA通过O4位与α-(1→2)-和α-(1→2,4)-Rhap的O2位交替连接所形成的重复单元[→4)-α-GalpA-(1→2)-α-Rhap-(1→]构成具有较高分支的“毛发区”(富含中性糖侧链的鼠李半乳糖醛酸聚糖). Galp和Araf是中性糖侧链的主要组成, 通过Rhap残基的O4位与主链相连. 非还原性末端T-β-Galp, β-(1→3)-, β-(1→3,6)-, β-(1→4)-, β-(1→4,6)-Galp聚合形成以β-(1→3,6)-Galp为分支点的β-(1→6)-半乳聚糖和以β-(1→4,6)-Galp为分支点的β-(1→4)-半乳聚糖. T-α-Araf, α-(1→5)-Araf和α-(1→3,5)-Araf聚合形成以α-(1→3,5)-Araf为分支点的α-(1→5)-阿拉伯聚糖. 此外, 由α-(1→5)-阿拉伯聚糖通过α-(1→3)连接与β-(1→6)-半乳聚糖末端聚合形成阿拉伯半乳聚糖.     

当归多糖ASP3的甲基化分析

通过部分酸水解和甲基化分析, 结合GC-MS测试手段, 对当归多糖ASP3的糖链结构进行了研究. 采用0.2 mol/L三氟乙酸(Trifluoroacetic acid, TFA)对ASP3进行了部分酸水解, 对水解前后的多糖组分进行甲基化分析. 结果显示: ASP3的糖残基主要由D-GalpA, D-Galp, L-Araf和L-Rhap组成, 主链由1,4-D-GalpA连接, 形成“光滑区”半乳糖醛酸聚糖, 由1,4-D-GalpA通过O-4位与1,2-; 1,2,4-L-Rhap的O-2位交替连接形成含有较多分支的“毛发区”鼠李半乳糖醛酸聚糖. 58.8%的Rhap残基发生O-4位取代(1,2,4-L-Rhap). 由T-, 1,5-, 1,3,5-Araf和T-, 1,3-, 1,3,6-, 1,4-, 1,4,6-D-Galp聚合形成的阿拉伯半乳聚糖、半乳聚糖以及阿拉伯聚糖是ASP3侧链的主要组成, 通过Rhap残基的O-4位与主链相连.     

不同提取方法对巴戟天中金属元素含量影响的初步探讨

采用了水提、醇提及模拟胃酸浓度的酸提法对巴戟天药材进行提取,并用火焰原子吸收分光光度法分别对其中的金属元素含量进行了测定。实验结果表明,三种提取方法中,醇提法金属溶出量最少,对于有害重金属含量较高的中药,可以在中药提取的工艺当中,利用不同的提取方法除去有害重金属。通过对三种提取方法所得的提取液中Pb、Cd的存在形态研究表明,Cd在工艺过程除去相对较容易,而Pb较困难,所以应在种植巴戟天时注意避免土壤及水源的Pb污染。     

南药巴戟天中十二种无机元素与药效关系的进一步研究

在初步研究的基础上，进一步研究了不同产地巴戟天的无机元素含量差异，通过对比各元素含量、相关系数及TE图谱，说明地道药材与非地道药材的巴戟天，其特征元素的含量存在非常明显的差异，要使大面积扩种的药材提高药效，建议根据当地土壤含Mn、Fe、Cr、Co、Ni的含量，以旋微量元素肥料的方法来补充这些元素在土壤中的不足。但在微量元素肥料配方中，应注意巴戟天吸收土壤中的元素时的协同作用和拮抗作用。     

南药巴戟天中十二种无机元素的初步研究

采用火焰原子吸收光谱法测定了不同产地和生长期的巴戟天中Mn．Fe．Cu．Zn、Ca、Mg、K、Na、Cr、Co、Ni、Pb等十二种无机元素的含量及其灰化率，为研究巴戟天的药效及栽培技术提供了实验数据．     

Chemical Fingerprint Analysis and Quantitative Analysis of Saccharides in Morindae Officinalis Radix by HPLC-ELSD

A method based on high performance liquid chromatography with evaporative light scattering detection (HPLC-ELSD) was developed for the quantitative analysis of three active compounds and chemical fingerprint analyses of saccharides in Morindae officinalis radix. Ten batches of Morindae officinalis radix were collected from different plantations in the Guangdong region of China and used to establish the fingerprint. The samples were separated with a COSMOIL Sugar-D column (4.6 mm × 250 mm, 5 μm) by using gradient elution with water (A) and acetonitrile (B). In addition, Trapped-Ion-Mobility (tims) Time-Of-Flight (tims TOF) was used to identify saccharides of Morindae officinalis radix. Fingerprint chromatogram presented 26 common characteristic peaks in the roots of Morinda officinalis How, and the similarities were more than 0.926. In quantitative analysis, the three compounds showed good regression (r = 0.9995–0.9998) within the test ranges, and the recoveries of the method were in the range of 96.7–101.7%. The contents of sucrose, kestose and nystose in all samples were determined as 1.21–7.92%, 1.02–3.37%, and 2.38–6.55%, respectively. The developed HPLC fingerprint method is reliable and was validated for the quality control and identification of Morindae officinalis radix and can be successfully used to assess the quality of Morindae officinalis radix.     

Discovery of New Iridoids as Farnesoid X Receptor Agonists from Morinda officinalis:Agonistic Potentials and Molecular Stimulation

Main observation and conclusion The investigation of Morinda officinalis led to the isolation of twelve compounds (1-12),including three new iridoid glycosides ...     

不同预处理方法对巴戟中砷限量检查的影响

采用５种不同预处理方法对巴戟药材进行处理，并用古蔡氏砷斑法检测其含量，发现不同处理方法的检测结果相差甚大，为中药砷限量检查中正确选择样品预处理方法提供了参考。     

Evaluation and quantitative analysis of 11 compounds in Morinda officinalis using ultra‐high performance liquid chromatography and photodiode array detection coupled with chemometrics

Morinda officinalis (Rubiaceae) is a traditional Chinese medicine widely used for the treatment of impotence and osteoporosis in clinical therapy. In the present study, a rapid and simple ultra‐high performance liquid chromatography with photodiode array detection method was developed and validated for the simultaneous determination of 11 bioactive compounds in M. officinalis . This assay method was validated with respect to linearity (R ²  > 0.9991), precision, repeatability, limit of detection, limit of quantification, and accuracy (with observed recovery rates between 94.21 and 100.38%). The quantitative results revealed significant differences in the concentrations of the selected compounds. Additionally, chemometric methods, including hierarchical clustering analysis, principal component analysis, and partial least‐squares discriminate analysis, were applied to compare and sort the 25 batches of M. officinalis samples based on the quantitative data of the analytes. All of the samples were clearly divided into two groups: the Hainan samples were successfully discriminated from the samples from other origins. Simultaneous determination of multiple compounds using the proposed method combined with chemometrics could be a viable strategy to compare and evaluate the quality of M. officinalis .     

Anthraquinones from Morinda officinalis roots enhance adipocyte differentiation in 3T3-L1 cells

To search for anti-diabetic and insulin-sensitising natural products, the effect on adipocyte differentiation was investigated by assessing fat accumulation in 3T3-L1 preadipocytes using Oil Red O staining. Fractionation and separation of n-hexane and CHCl? fractions of Morinda officinalis (Rubiaceae) using several chromatographic methods led to the isolation of three anthraquinones, 1,2-dimethoxyanthraquinone (1), alizarin-2-methyl ether (2) and rubiadin-1-methyl ether (3). Among them, alizarin-2-methyl ether (2) showed the strongest enhancing activity, followed by rubiadin-1-methyl ether (3) and 1,2-dimethoxyanthraquinone (1). At a concentration of 100?μM, alizarin-2-methyl ether (2) enhanced adipocyte differentiation by up to 131% (compared to insulin-treated cells). Thus, these compounds could be beneficial in the treatment of diabetes.     

巴戟天内生真菌Trichoderma spirale A725中两个新的聚酮类化合物(英文)

综合运用硅胶柱色谱、反相硅胶柱色谱、Sephadex LH-20凝胶柱色谱以及制备型高效液相色谱技术对药用植物巴戟天内生真菌Trichoderma spirale A725的次生代谢产物进行分离纯化,得到6个聚酮类化合物,采用多种现代波谱技术确定其结构,分别为:6-羟基-4-异丙基-1,8-二甲基螺环[4.5]癸-1,8-二烯-7-酮(1),2-羟基-2,5-二甲基-7-氧代-5,7-二氢-2H-呋喃[3,4-b]吡喃-4-羧酸(2), 3-乙基-4-羟基-6-甲基-二氢-吡喃-2-酮(3),苯乙内酯A (4), 3-羟基-5-(4-羟基苄基)二氢呋喃-2(3H)-酮(5), 4-乙酰-3-羟基-6-甲基吡喃-2-酮(6).其中化合物1和2为新化合物,化合物3为新天然产物.此外,利用四株肿瘤细胞株(Hep G-2、MCF-7、SF-268及A549)对化合物1~6细胞毒活性进行评估,结果表明化合物1~6对上述肿瘤细胞均无明显的细胞毒活性.     

Buddleja officinalis Maximowicz extract inhibits lipid accumulation on adipocyte differentiation in 3T3-L1 cells and high-fat mice

Obesity is a global health problem. It is also known to be a risk factor for the development of metabolic disorders, type 2 diabetes, systemic hypertension, cardiovascular disease, dyslipidemia, and atherosclerosis. In this study, we elucidated that Buddleja officinalis Maximowicz extract significantly inhibited lipid accumulation during 3T3-L1 adipocyte differentiation. Furthermore, Buddleja officinalis Maximowicz extract reduced the body weight gain induced through feeding a high-fat diet to C57BL/6 mice. The treatment of Buddleja officinalis Maximowicz extract significantly reduced the adipose tissue weight to 2.7/100 g of body weight in high-fat mice. When their adipose tissue morphology was investigated for histochemical staining, the distribution of cell size in the high-fat diet groups was hypertrophied compared with those from Buddleja officinalis Maximowicz extract-treated mice. In addition, in Buddleja officinalis Maximowicz extract-treated mice, a significant reduction of serum triglyceride and T-cholesterol was observed at to 21% and 17%, respectively. The discovery of bioactive compounds from diet or dietary supplementation is one of possible ways to control obesity and to prevent or reduce the risks of various obesity-related diseases. These results support that Buddleja officinalis Maximowicz extract is expected to create the therapeutic interest with respect to the treatment of obesity.